Pharmacy Review for Total and Permanent Disability (TPD) Claims

Strengthen TPD assessment through specialist medication review and analysis

Published: 3 April 2026 | Updated: 3 April 2026

Why TPD Claims Require Specialist Medication Review

Total and permanent disability claims require rigorous assessment of long-term functional capacity. Your decision determines a lifetime benefit entitlement. Medical evidence is central, but medication management often reveals the true clinical picture. A claimant's complex medication regime may indicate genuine medical complexity and permanent impairment, or it may reflect over-treatment, medication accumulation, or inadequate disease management.

Your TPD assessment team works from medical reports and diagnosis codes. But pharmacy-level insight is essential: Are medications appropriate? Are doses justified? Is the medication regime itself sustainable or creating long-term risk? Does medication management support genuine permanent impairment, or does it suggest the claimant's functional limitations are reversible with appropriate medication management? You need specialist pharmacy review. IMM's pharmacist-led assessments provide the medication analysis that strengthens your TPD decision-making.

What IMM Reviews in TPD Claims

Medication Necessity and Indication Alignment

We examine each medication and assess clear clinical justification, alignment with documented diagnoses, and ongoing necessity. For TPD claims, we assess whether the medication regime reflects genuinely permanent medical needs or whether significant deprescribing is feasible, suggesting reversibility rather than permanence.

Dosing Appropriateness and Long-Term Sustainability

TPD claims assume permanent medication dependency. We benchmark doses against evidence-based guidelines and assess whether doses reflect permanent medical need or could be reduced as disease stabilises. Unusually high doses may suggest inadequate disease control (red flag for permanent impairment) or over-treatment (red flag against permanence).

Drug Interactions and Long-Term Safety Risk

For permanent medication regimes, drug interactions create long-term safety concerns. We screen comprehensively and identify interactions that suggest medication management is unsustainable long-term or creates permanent disability risk independent of the underlying condition.

Medication-Related Permanent Disability Assessment

Some medications create permanent functional limitations independent of underlying disease. Others cause progressive harm (organ damage, dependency, tolerance). We assess whether the medication regime itself creates permanent disability or whether medications are supporting function and reversibility.

Disease Control and Stability Alignment

For TPD, appropriate medications should result in disease control and functional stability. Disconnect between medication burden and clinical outcomes is a red flag. If complex medications are not achieving disease control or functional stability, permanence is questionable.

How Pharmacy Review Informs TPD Claims Assessment

Real-World Scenario: TPD Claim Assessment

Situation: A 54-year-old claimant lodges a TPD claim citing multiple chronic conditions: chronic pain, depression, anxiety disorder, sleep disorder, and hypertension. Current medications: oxycodone, pregabalin, duloxetine, sertraline, alprazolam, zopiclone, metoprolol, enalapril, and simvastatin. Medical records describe "complex medical picture" and "multiple comorbidities." Your assessor must determine whether functional limitation is permanent or potentially reversible with appropriate medication management.

IMM Review Findings: Medication regime shows significant duplication and over-escalation. Duloxetine and sertraline both treat depression via serotonin pathways; combination is excessive. Alprazolam and zopiclone both create sedation; combination contraindicated and suggests benzodiazepine dependence. Pregabalin, oxycodone, and duloxetine all treat neuropathic pain; combined dosing exceeds evidence recommendations. Oxycodone dose at 60mg daily is very high. Enalapril and metoprolol for hypertension management are appropriate, but blood pressure control adequacy is unclear. Overall, medication regime suggests poorly coordinated prescribing, over-treatment of pain and anxiety, and benzodiazepine dependence rather than permanent medical conditions requiring high-complexity medication management.

Outcome: IMM's review supports your assessment that while claimant has genuine medical conditions (pain, depression, anxiety, hypertension), the medication regime suggests over-treatment and poor coordination rather than permanent irreversible functional limitation. Deprescribing is feasible: reduce oxycodone, reduce pregabalin, continue either duloxetine or sertraline (not both), taper alprazolam and zopiclone. With appropriate medication optimisation, functional capacity improvement is likely. TPD claim is not supported; case is declined or downgraded to income protection consideration.

Medication Patterns in TPD Claims: Red Flags and Green Lights

Red flags (suggest reversibility): Multiple sedating medications without documented indication; high doses exceeding evidence recommendations; rapid medication escalation; medications contradicting each other; benzodiazepines or opioids beyond recommended duration; medication-induced complications (falls, delirium, sexual dysfunction) not addressed.

Green flags (suggest permanence): Medications aligned with documented diagnoses and evidence-based guidelines; appropriate doses for disease control; stable long-term medication regimen without escalation; medications addressing disease-specific mechanisms; appropriate disease control and functional outcomes with medication support; healthcare provider coordination and oversight.

Medication Categories Common in TPD Claims

Practical Implementation for Your TPD Process

At lodgement: If the claimant's medical summary includes complex medications or polypharmacy, request pharmacy review early to establish baseline appropriateness and identify medication-related concerns.

During investigation: Use IMM's findings to inform your permanence assessment. Does the medication regime support or contradict claimed permanent disability?

At decision: Reference IMM's medication analysis in your decision documentation. Pharmacy review strengthens your TPD decision through evidence-based medication assessment.